Sumanta K. Pal discusses CD70-Targeted Allogeneic CAR T-Cell Therapy for ccRCC – Cancer Discovery

“Published by a nonprofit professional society, the journal enhances knowledge and supports the cancer research community. Watch Dr. Sumanta K. Pal discuss his research, CD70-Targeted Allogeneic CAR T-Cell Therapy for ccRCC, published concurrently at AACR24.”

Source: Cancer Discovery/X

Sumanta (Monty) Pal, MD, is a medical oncologist and an expert in genitourinary cancers at the City of Hope Comprehensive Cancer Center in Los Angeles. He serves as the co-director of the Kidney Cancer Program and leads the Kidney and Bladder Cancer Disease Team at City of Hope. He specialises in kidney, bladder, and prostate cancers.